Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 598
- 试验地点
- 75
- 主要终点
- Management
研究概览
简要总结
ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS.
Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear
详细描述
There are limited data available, particularly from a representative population-based perspective describing recent pharmacological and non-pharmacological management and clinical event rates associated with AF complicating ACS in the era of novel treatment strategies (in both AF and ACS) and high coronary reperfusion rates.
This registry will assess the current in-hospital management and clinical events at 6 months of consecutive patients admitted in Italian cardiology intensive care units (CCUs) for an ACS treated invasively with PCI and stent implantation who present AF at admission or during hospital stay, before or after stent implantation .
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All consecutive ACS patients treated with PCI with stent implantation who present AF at admission or during hospital stay, before or after stent implantation.
排除标准
- •Patients admitted with a diagnosis of ACS at the time of enrolment but not confirmed during hospitalization
- •ACS treated medically or with PCI but without stent implantation
- •Patients not giving informed consent
结局指标
主要结局
Management
时间窗: 6 months
Time of PCI
Number of procedure performed on enrolled patients
时间窗: 6 months
In-hospital management
Clinical epidemiology
时间窗: Enrollement
Type of ACS
Antithrombotic strategy
时间窗: 6 months
Intravenous or oral antiplatelet and anticoagulation therapies and their combination
次要结局
- Clinical outcomes(6 months)
- Pharmacological therapies(6 months)